CANY
MNOV icon

Caxton Associates (New York)’s MediciNova MNOV Stock Holding History

Caxton Associates (New York)’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,247
Closed -$56K – 535
2021
Q2 		$56K Hold
13,247
– – 0.01% 457
2021
Q1 		$67K Buy
+13,247
New +$77.1K 0.01% 408

Other funds holding MNOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Caxton Associates (New York)'s MNOV Position: Q3 2021 in Review

Caxton Associates (New York) sold out of MediciNova (MNOV) in Q3 2021, closing a stake of 13,247 shares — an estimated $56K sold.

Caxton Associates (New York) first reported a position in MNOV in Q1 2021 and held it in 2 quarters. The position peaked at $67K in Q1 2021. 39 funds tracked by Wall St. Rank hold MNOV as of Q3 2021.

  • Caxton Associates (New York) reported no remaining MediciNova position as of Q3 2021 after selling out during the quarter.
  • Caxton Associates (New York) sold 13,247 MediciNova shares in Q3 2021, an estimated $56K.
  • Caxton Associates (New York) first reported a position in MediciNova in Q1 2021 and held it in 2 quarters.
  • Caxton Associates (New York)'s MediciNova position peaked at $67K in Q1 2021.
  • 39 funds tracked by Wall St. Rank held MediciNova as of Q3 2021.

Based on Caxton Associates (New York)'s 13F filing for Q3 2021, filed 15 Nov 2021.